Drug Prices

May 15, 2018
The Senate Health, Education, Labor and Pensions Committee today held the second in a series of hearings examining the 340B drug savings program.   At the hearing, representatives from the Department of Health and Human Services Office of Inspector General and Government Accountability Office…
May 14, 2018
Health and Human Services Secretary Alex Azar today provided additional information on steps the agency will take to implement the president’s blueprint to lower prescription drug costs. “In short order, we will be issuing a request for proposal to make new use of an alternative system for buying…
May 11, 2018
President Trump today unveiled his administration’s blueprint to lower prescription drug prices, which also solicits input on potential actions the Department of Health and Human Services may take to improve competition and negotiation and lower costs. Among other actions, for example, HHS may…
May 22, 2018
AHA today urged the Health Resources and Services Administration to implement without further delay its final regulation on 340B drug ceiling prices and civil monetary penalties for manufacturers. “By failing to implement the final rule, drug manufacturers can continue to overcharge 340B…
May 18, 2018
Medicare Part D prescription drug plans should not prevent pharmacies from telling customers when they could pay less for a drug by paying cash, the Centers for Medicare & Medicaid Services told plan sponsors yesterday. “An important step in putting patients first and lowering out-of-pocket…
May 18, 2018
House Speaker Paul Ryan (R-WI) yesterday discussed a potential compromise on the Creating and Restoring Equal Access to Equivalent Samples Act (S. 974/H.R. 2212), as part of congressional action to address high drug prices. “We’re working between the Commerce Committee and the Judiciary Committee…
May 15, 2018
The Centers for Medicare & Medicaid Services today updated the Parts B and D drug spending dashboards with 2016 information. The dashboards provide pricing and utilization information for drugs covered under Medicare Parts B and D, including the total amount the program spent on a covered drug…
May 14, 2018
The Department of Health and Human Services May 14, issued a policy statement and request for information (RFI) on ways to lower drug prices and reduce out-of-pocket costs for consumers.
May 14, 2018
Another week, another drug industry-funded consultant attempting to divert attention away from the high and rising costs of prescription drugs by attacking the 340B drug pricing program. Such efforts are intended to not only shift attention away from manufacturers’ bad pricing behavior, but also to…
May 11, 2018
Contact:  Marie Johnson, (202) 626-2351                Colin Milligan, (202) 638-5491 Rick Pollack AHA President and CEO May 11, 2018 The AHA applauds President Trump and his administration for taking the initiative to tackle the high price of…